{"nctId":"NCT05487300","briefTitle":"Effect of Levodopa on Cardiovascular Autonomic Function in Parkinson's Disease","startDateStruct":{"date":"2022-05-11","type":"ACTUAL"},"conditions":["Parkinson Disease","Orthostatic Hypotension"],"count":40,"armGroups":[{"label":"Testing on-levodopa first, then off-levodopa","type":"OTHER","interventionNames":["Drug: Autonomic testing on and off levodopa"]},{"label":"Testing off-levodopa, then on-levodopa","type":"OTHER","interventionNames":["Drug: Autonomic testing on and off levodopa"]}],"interventions":[{"name":"Autonomic testing on and off levodopa","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Subjects with a diagnosis of Parkinson's disease\n* For the subgroup of participants with orthostatic hypotension (OH), OH will be defined by a sustained drop in systolic blood pressure \\> 20 mmHg and/or a drop in diastolic blood pressure \\> 10 mmHg within 3 minutes from supine to standing during tilt not attributable to medications. Autonomic testing and a ratio of orthostatic heart rate change/systolic blood pressure change \\< 0.5 bpm/mmHg will confirm the neurogenic etiology.\n\nExclusion Criteria:\n\n* Any medication indicated for withdrawal that would result in undue risk to the participant if discontinued or that would confound heart rate and blood pressure measures\n* Cognitive impairment that limits the ability to follow instructions","healthyVolunteers":false,"sex":"ALL","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change in Systolic Blood Pressure From Supine to Tilt at 3 Minutes","description":"Change in systolic blood pressure from supine to tilt at 3 minutes","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-24.22","spread":"17.69"},{"groupId":"OG001","value":"-20.32","spread":"19.88"}]}]}]},{"type":"SECONDARY","title":"Baroreflex Cardiovagal Function","description":"Index of cardiovagal function: cardiovagal baroreflex sensitivity (BRS-V) \\[lower scores = worse outcome\\]. The BRS-V is the slope of the relationship between cardiac R-R interval and blood pressure in phase II of the Valsalva maneuver","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.49","spread":"2.39"},{"groupId":"OG001","value":"2.02","spread":"2.16"}]}]}]},{"type":"SECONDARY","title":"Baroreflex Adrenergic Sensitivity","description":"Baroreflex adrenergic sensitivity (BRS-A) in mmHg/s \\[lower scores = worse outcome\\]. The BRS-A was calculated as the systolic blood pressure decrement associated with phase 3 of the Valsalva maneuver divided by the blood pressure recovery time","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.29","spread":"6.51"},{"groupId":"OG001","value":"6.88","spread":"6.73"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":38},"commonTop":[]}}}